.Venture capital funding right into biopharma cheered $9.2 billion around 215 deals in the second qu...
.Bicara Therapies and also Zenas Biopharma have actually provided fresh motivation to the IPO market...
.Genentech will close its own cancer immunology study team, as well as unit mind and also prominent ...
.Kezar Life Sciences is actually falling its unpromising stage 1 strong tumor medicine as the biotec...
.Regardless of izokibep sustaining its newly found winning streak in the clinic, Acelyrin is no long...
.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medication ap...
.Ovid Therapy actually revealed last month that it was actually trimming back its own head count as ...
.Eli Lilly has actually opened a $700 thousand R&D facility in the Boston Seaport, increasing its...
.Just 5 months after safeguarding a $100 million IPO, Vast Biography is actually laying off some emp...
.The preliminary phases of oncology R&D may not be short of appealing new methods, as well as Hal...